Literature DB >> 33931741

Long non-coding RNA SMASR inhibits the EMT by negatively regulating TGF-β/Smad signaling pathway in lung cancer.

Lele Xu1, Wenzhong Liu1, Tongtong Li1, Yuying Hu2, Yu Wang1, Lijie Huang1, Yan Wang2, Shujuan Shao3, Xuefeng Liu4, Qimin Zhan5,6.   

Abstract

TGF-β/Smad signaling pathway plays an important role in EMT during cancer progression. Long non-coding RNAs (lncRNAs) are involved in various behaviors of cancer cells, including EMT. Here, we report a novel lncRNA adjacent to Smad3, named Smad3-associated long non-coding RNA (SMASR). SMASR is downregulated by TGF-β via Smad2/3 in lung cancer cells. Knockdown of SMASR induces EMT and increases the migration and invasion of lung cancer cells. Moreover, knockdown of SMASR promotes the phosphorylation of Smad2/3. Mechanistically, SMASR interacts with Smad2/3 and inhibits the expression of TGFBR1, the TGF-β type I receptor responsible for phosphorylation of Smad2/3, thus leading to inactivation of TGF-β/Smad signaling pathway. Clinically, SMASR is downregulated in lung cancer tissues. Collectively, our findings prove a critical role of SMASR in EMT of lung cancer by forming a negative feedback loop with TGF-β/Smad signaling pathway.

Entities:  

Mesh:

Substances:

Year:  2021        PMID: 33931741     DOI: 10.1038/s41388-021-01760-2

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  51 in total

Review 1.  Epithelial-mesenchymal transitions in tumour progression.

Authors:  Jean Paul Thiery
Journal:  Nat Rev Cancer       Date:  2002-06       Impact factor: 60.716

2.  lncRNA Epigenetic Landscape Analysis Identifies EPIC1 as an Oncogenic lncRNA that Interacts with MYC and Promotes Cell-Cycle Progression in Cancer.

Authors:  Zehua Wang; Bo Yang; Min Zhang; Weiwei Guo; Zhiyuan Wu; Yue Wang; Lin Jia; Song Li; Wen Xie; Da Yang
Journal:  Cancer Cell       Date:  2018-04-02       Impact factor: 31.743

3.  TGF-beta and the Smad signaling pathway support transcriptomic reprogramming during epithelial-mesenchymal cell transition.

Authors:  Ulrich Valcourt; Marcin Kowanetz; Hideki Niimi; Carl-Henrik Heldin; Aristidis Moustakas
Journal:  Mol Biol Cell       Date:  2005-02-02       Impact factor: 4.138

Review 4.  TGFbeta signalling: a complex web in cancer progression.

Authors:  Hiroaki Ikushima; Kohei Miyazono
Journal:  Nat Rev Cancer       Date:  2010-06       Impact factor: 60.716

5.  An epithelial-mesenchymal transition gene signature predicts resistance to EGFR and PI3K inhibitors and identifies Axl as a therapeutic target for overcoming EGFR inhibitor resistance.

Authors:  Lauren Averett Byers; Lixia Diao; Jing Wang; Pierre Saintigny; Luc Girard; Michael Peyton; Li Shen; Youhong Fan; Uma Giri; Praveen K Tumula; Monique B Nilsson; Jayanthi Gudikote; Hai Tran; Robert J G Cardnell; David J Bearss; Steven L Warner; Jason M Foulks; Steven B Kanner; Varsha Gandhi; Nancy Krett; Steven T Rosen; Edward S Kim; Roy S Herbst; George R Blumenschein; J Jack Lee; Scott M Lippman; K Kian Ang; Gordon B Mills; Waun K Hong; John N Weinstein; Ignacio I Wistuba; Kevin R Coombes; John D Minna; John V Heymach
Journal:  Clin Cancer Res       Date:  2012-10-22       Impact factor: 12.531

Review 6.  The basics of epithelial-mesenchymal transition.

Authors:  Raghu Kalluri; Robert A Weinberg
Journal:  J Clin Invest       Date:  2009-06       Impact factor: 14.808

7.  Targeted disruption of TGF-beta1/Smad3 signaling protects against renal tubulointerstitial fibrosis induced by unilateral ureteral obstruction.

Authors:  Misako Sato; Yasuteru Muragaki; Shizuya Saika; Anita B Roberts; Akira Ooshima
Journal:  J Clin Invest       Date:  2003-11       Impact factor: 14.808

Review 8.  TGF-beta-induced epithelial to mesenchymal transition.

Authors:  Jian Xu; Samy Lamouille; Rik Derynck
Journal:  Cell Res       Date:  2009-02       Impact factor: 25.617

Review 9.  New insights into the mechanisms of epithelial-mesenchymal transition and implications for cancer.

Authors:  Anushka Dongre; Robert A Weinberg
Journal:  Nat Rev Mol Cell Biol       Date:  2019-02       Impact factor: 94.444

10.  TGF-beta induced transdifferentiation of mammary epithelial cells to mesenchymal cells: involvement of type I receptors.

Authors:  P J Miettinen; R Ebner; A R Lopez; R Derynck
Journal:  J Cell Biol       Date:  1994-12       Impact factor: 10.539

View more
  6 in total

Review 1.  Epithelial-mesenchymal transition: The history, regulatory mechanism, and cancer therapeutic opportunities.

Authors:  Zhao Huang; Zhe Zhang; Chengwei Zhou; Lin Liu; Canhua Huang
Journal:  MedComm (2020)       Date:  2022-05-18

2.  Downregulation of LNMAS orchestrates partial EMT and immune escape from macrophage phagocytosis to promote lymph node metastasis of cervical cancer.

Authors:  Yuandong Liao; Jiaming Huang; Pan Liu; Chunyu Zhang; Junxiu Liu; Meng Xia; Chunliang Shang; Shiyin Ooi; Yili Chen; Shuhang Qin; Qiqiao Du; Tianyu Liu; Manman Xu; Qiaojian Zou; Yijia Zhou; Hua Huang; Yuwen Pan; Wei Wang; Shuzhong Yao
Journal:  Oncogene       Date:  2022-02-12       Impact factor: 8.756

3.  LncRNA SLC16A1-AS1 contributes to the progression of hepatocellular carcinoma cells by modulating miR-411/MITD1 axis.

Authors:  Chun Duan
Journal:  J Clin Lab Anal       Date:  2022-03-15       Impact factor: 2.352

Review 4.  Long Non-Coding RNA Neighbor of BRCA1 Gene 2: A Crucial Regulator in Cancer Biology.

Authors:  Ting Wang; Zhaosheng Li; Liujia Yan; Feng Yan; Han Shen; Xinyu Tian
Journal:  Front Oncol       Date:  2021-12-02       Impact factor: 6.244

5.  LINC00152 induced by TGF-β promotes metastasis via HuR in lung adenocarcinoma.

Authors:  Wei Xu; Linna Chen; Jiheng Liu; Zhezhe Zhang; Ranran Wang; Qianqian Zhang; Huiting Li; Juanjuan Xiang; Li Fang; Ping Xu; Zheng Li
Journal:  Cell Death Dis       Date:  2022-09-07       Impact factor: 9.685

6.  A Regulatory Network Analysis of the Importance of USP15 in Breast Cancer Metastasis and Prognosis.

Authors:  Jun Ling; Chenhui Qin; Tao Li; Baozhen Wang; Weiji Cai; Lei Ma; Yanfeng Wang; Jing Chen; Fang Xu
Journal:  J Oncol       Date:  2022-09-29       Impact factor: 4.501

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.